Trupanion (NASDAQ:TRUP) COO Sells $10,809.48 in Stock

Trupanion, Inc. (NASDAQ:TRUPGet Free Report) COO John Gallagher sold 431 shares of the firm’s stock in a transaction dated Tuesday, July 28th. The stock was sold at an average price of $25.08, for a total value of $10,809.48. Following the completion of the transaction, the chief operating officer directly owned 32,203 shares in the company, valued at $807,651.24. This trade represents a 1.32% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Trupanion Stock Up 0.0%

TRUP stock opened at $24.49 on Friday. The business’s 50-day moving average price is $24.33 and its 200-day moving average price is $26.48. The stock has a market cap of $1.07 billion, a P/E ratio of 41.51 and a beta of 1.39. The company has a quick ratio of 1.73, a current ratio of 1.73 and a debt-to-equity ratio of 0.25. Trupanion, Inc. has a twelve month low of $21.16 and a twelve month high of $57.00.

Trupanion (NASDAQ:TRUPGet Free Report) last released its earnings results on Thursday, April 30th. The financial services provider reported $0.11 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.07 by $0.04. Trupanion had a net margin of 1.74% and a return on equity of 6.87%. The company had revenue of $384.05 million during the quarter, compared to analyst estimates of $379.77 million. During the same period in the prior year, the firm posted ($0.03) EPS. The firm’s quarterly revenue was up 12.3% compared to the same quarter last year. On average, equities research analysts forecast that Trupanion, Inc. will post 0.55 EPS for the current year.

Hedge Funds Weigh In On Trupanion

Several hedge funds have recently modified their holdings of the stock. Thrivent Financial for Lutherans grew its stake in Trupanion by 1.1% during the second quarter. Thrivent Financial for Lutherans now owns 24,853 shares of the financial services provider’s stock valued at $1,376,000 after acquiring an additional 282 shares in the last quarter. EP Wealth Advisors LLC boosted its holdings in shares of Trupanion by 2.9% during the 2nd quarter. EP Wealth Advisors LLC now owns 10,310 shares of the financial services provider’s stock valued at $571,000 after purchasing an additional 292 shares during the last quarter. Illinois Municipal Retirement Fund boosted its holdings in shares of Trupanion by 2.3% during the 1st quarter. Illinois Municipal Retirement Fund now owns 17,819 shares of the financial services provider’s stock valued at $456,000 after purchasing an additional 406 shares during the last quarter. Price T Rowe Associates Inc. MD grew its position in shares of Trupanion by 2.2% during the fourth quarter. Price T Rowe Associates Inc. MD now owns 33,657 shares of the financial services provider’s stock valued at $1,258,000 after purchasing an additional 725 shares in the last quarter. Finally, MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its position in shares of Trupanion by 3.8% during the second quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 20,340 shares of the financial services provider’s stock valued at $1,126,000 after purchasing an additional 737 shares in the last quarter.

Analyst Upgrades and Downgrades

A number of analysts have recently issued reports on the stock. Cantor Fitzgerald reduced their price objective on shares of Trupanion from $42.00 to $34.00 and set a “neutral” rating for the company in a research note on Thursday, April 9th. Weiss Ratings restated a “sell (d+)” rating on shares of Trupanion in a research note on Monday, June 1st. Zacks Research raised shares of Trupanion from a “hold” rating to a “strong-buy” rating in a report on Friday, July 24th. Stifel Nicolaus set a $28.00 price target on Trupanion in a research note on Friday, June 26th. Finally, Atlantic Securities set a $42.00 price target on Trupanion in a report on Wednesday, July 15th. One equities research analyst has rated the stock with a Strong Buy rating, two have assigned a Buy rating, two have issued a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, Trupanion presently has a consensus rating of “Moderate Buy” and a consensus price target of $41.60.

View Our Latest Report on TRUP

About Trupanion

(Get Free Report)

Trupanion, Inc is a pet medical insurance company that provides comprehensive insurance coverage for cats and dogs. The company’s core offering is a single, customizable medical policy designed to cover veterinary diagnostic tests, surgeries, hospital stays and congenital or hereditary conditions. Trupanion seeks to streamline the claims process by offering direct payment options to participating veterinarians, reducing the need for upfront payments by pet owners.

Founded in 1999 by Darryl Rawlings and headquartered in Seattle, Washington, Trupanion began operations in the early 2000s and has grown its presence through both digital channels and partnerships with veterinary hospitals.

Featured Articles

Insider Buying and Selling by Quarter for Trupanion (NASDAQ:TRUP)

Receive News & Ratings for Trupanion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion and related companies with MarketBeat.com's FREE daily email newsletter.